These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 316328

  • 1. Danazol's failure to suppress autoimmunity in NZB/NZW F1 mice.
    Roubinian JR, Talal N, Greenspan JS, Goodman JR, Nussenzweig V.
    Arthritis Rheum; 1979 Dec; 22(12):1399-1402. PubMed ID: 316328
    [No Abstract] [Full Text] [Related]

  • 2. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
    Gunn HC.
    Clin Exp Immunol; 1986 May; 64(2):225-33. PubMed ID: 3488856
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic studies in New Zealand mice. VII. Successful androgen treatment of NZB/NZW F1 females of different ages.
    Melez KA, Boegel WA, Steinberg AD.
    Arthritis Rheum; 1980 Jan; 23(1):41-7. PubMed ID: 7352943
    [No Abstract] [Full Text] [Related]

  • 4. Preliminary observations on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement.
    Agnello V, Pariser K, Gell J, Gelfand J, Turksoy RN.
    J Rheumatol; 1983 Oct; 10(5):682-7. PubMed ID: 6606038
    [Abstract] [Full Text] [Related]

  • 5. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB x NZW)F1 mice.
    Hirose S, Tokushige K, Kinoshita K, Nozawa S, Saito J, Nishimura H, Shirai T.
    Eur J Immunol; 1991 Mar; 21(3):823-6. PubMed ID: 1826267
    [Abstract] [Full Text] [Related]

  • 6. [Danazol and autoimmune thrombocytopenia in systemic lupus erythematosus].
    Selva A, Jordana R, Tolosa C, Ordi J.
    Med Clin (Barc); 1990 Apr 14; 94(14):557-8. PubMed ID: 2355774
    [No Abstract] [Full Text] [Related]

  • 7. [The effect of inducers of endogenous interferon on the course of an autoimmune process in F1 inbred NZB/NZW mice].
    Nasonova VA, Balabanova RM, Pleskovskaia GN, Venikova MS, Poverennyĭ AM, Podgorodnichenko VK, Popova GA.
    Vopr Virusol; 1990 Apr 14; 35(5):408-11. PubMed ID: 2267785
    [No Abstract] [Full Text] [Related]

  • 8. Danazol for Evan's syndrome due to SLE.
    Aranegui P, Giner P, Lopez-Gomez M, el Amrani A, Jimenez-Alonso J.
    DICP; 1990 Jun 14; 24(6):641-2. PubMed ID: 2360344
    [No Abstract] [Full Text] [Related]

  • 9. Spontaneous autoimmune disease in (NZB x NZW)F1 mice is ameliorated by treatment with methimazole.
    Mozes E, Zinger H, Kohn LD, Singer DS.
    J Clin Immunol; 1998 Mar 14; 18(2):106-13. PubMed ID: 9533654
    [Abstract] [Full Text] [Related]

  • 10. The effect of danazol in the MRL/lpr mouse model of autoimmune disease.
    Connolly KM, Stecher VJ, Snyder BW, Bohnet E, Potts GO.
    Agents Actions; 1988 Aug 14; 25(1-2):164-70. PubMed ID: 3189043
    [Abstract] [Full Text] [Related]

  • 11. Ribavirin: efficacy in the treatment of murine autoimmune disease.
    Klassen LW, Budman DR, Williams GW, Steinberg AD, Gerber NL.
    Science; 1977 Feb 25; 195(4280):787-9. PubMed ID: 299957
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
    McMurray RW, Elbourne KB, Lagoo A, Lal S.
    J Rheumatol; 1998 Dec 25; 25(12):2364-70. PubMed ID: 9858431
    [Abstract] [Full Text] [Related]

  • 13. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.
    Reininger L, Winkler TH, Kalberer CP, Jourdan M, Melchers F, Rolink AG.
    J Exp Med; 1996 Sep 01; 184(3):853-61. PubMed ID: 9064345
    [Abstract] [Full Text] [Related]

  • 14. Study of thymic factors. II. Failure of thymosin to alter the natural history of NZB and NZB/NZW mice.
    Gershwin ME, Steinberg AD, Ahmed A, Derkay C.
    Arthritis Rheum; 1976 Sep 01; 19(5):862-6. PubMed ID: 1085626
    [Abstract] [Full Text] [Related]

  • 15. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
    Wellmann U, Letz M, Schneider A, Amann K, Winkler TH.
    Int Immunol; 2001 Dec 01; 13(12):1461-9. PubMed ID: 11717187
    [Abstract] [Full Text] [Related]

  • 16. DNAse treatment does not improve the survival of lupus prone (NZB x NZW)F1 mice.
    Verthelyi D, Dybdal N, Elias KA, Klinman DM.
    Lupus; 1998 Dec 01; 7(4):223-30. PubMed ID: 9643311
    [Abstract] [Full Text] [Related]

  • 17. Reversal of lupus-erythematosus-like disease with danazol.
    Masse R, Youinou P, Dorval JC, Cledes J.
    Lancet; 1980 Sep 20; 2(8195 pt 1):651. PubMed ID: 6107447
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb 20; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 19. Effect of danazol on lupus-erythematosus-like disease in hereditary angioneurotic oedema.
    Donaldson VH, Hess EV.
    Lancet; 1980 Nov 22; 2(8204):1145. PubMed ID: 6107762
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M, Yu G, Chan B, Pearson JT, Rathanaswami P, Delaney J, Ching Lim A, Babcook J, Hsu H, Gavin MA.
    Arthritis Rheumatol; 2015 Oct 22; 67(10):2723-31. PubMed ID: 26097207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.